{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:10:04Z","timestamp":1791360604123,"version":"4.3.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2831,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Although it is often functional at presentation, acute renal failure has a poor prognosis in patients with cirrhosis. The role of inflammation, a key event in the outcome of cirrhosis, has never been studied in this setting. We aimed to investigate the predictive factors of mortality in patients with cirrhosis and acute functional renal failure, specifically in relation to inflammatory events. One hundred consecutive patients with cirrhosis from 5 French hospitals were prospectively included at the day of onset of acute renal failure. Medical history, treatments, and procedures during the month before inclusion were recorded. Physical examination, blood and urinary chemistries, and renal ultrasound examination were performed. The presence of systemic inflammatory response syndrome (SIRS), infection, and sepsis was assessed. The primary outcome was in-hospital mortality. The mechanism of renal failure was functional in 83 patients. Causes of renal failure were hypovolemia (34%), hepatorenal syndrome without ongoing infection (17%), hepatorenal syndrome with ongoing infection (16%), nephrotoxicity (2%), and multifactorial (31%). SIRS was observed in 41% of patients, 56% of them with infection. In-hospital mortality was 68% in patients with SIRS and 33% in patients without (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.001). In multivariate analysis, only model for end-stage liver disease score and presence of SIRS, but not infection, remained associated with a poor outcome.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>The presence of SIRS, with or without infection, is a major independent prognostic factor in patients with cirrhosis and acute functional renal failure. This suggests that preventing and treating SIRS could decrease mortality in patients with cirrhosis and acute renal failure. (Hepatology 2007.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21920","type":"journal-article","created":{"date-parts":[[2007,10,31]],"date-time":"2007-10-31T07:46:31Z","timestamp":1193816791000},"page":"1872-1882","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":225,"title":["Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure"],"prefix":"10.1097","volume":"46","author":[{"given":"Dominique","family":"Thabut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Gangloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lebrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20241201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD.","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"R2-26-20241201","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"R3-26-20241201","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1572-0241.2000.01772.x","article-title":"Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction.","volume":"95","author":"Afessa","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R4-26-20241201","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"R5-26-20241201","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199605303342207","article-title":"Acute renal failure.","volume":"334","author":"Thadhani","year":"1996","journal-title":"N Engl J Med"},{"key":"R6-26-20241201","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"R7-26-20241201","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2003\/370257","article-title":"Renal impairment after spontaneous bacterial peritonitis: incidence and prognosis.","volume":"17","author":"Perdomo Coral","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"R8-26-20241201","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"38","author":"RuizdelArbol","year":"2003","journal-title":"Hepatology"},{"key":"R9-26-20241201","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"R10-26-20241201","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"R11-26-20241201","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis.","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-26-20241201","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1478-3231.2003.00870.x","article-title":"Coagulation disorders in patients with cirrhosis and severe sepsis.","volume":"23","author":"Plessier","year":"2003","journal-title":"Liver Int"},{"key":"R13-26-20241201","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"key":"R14-26-20241201","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for endstage liver disease (MELD).","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"R15-26-20241201","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with endstage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R16-26-20241201","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices.","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R17-26-20241201","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","article-title":"Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis.","volume":"120","author":"GarciaTsao","year":"2001","journal-title":"Gastroenterology"},{"key":"R18-26-20241201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"R19-26-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bpg.2006.10.004","article-title":"Diagnosis and treatment of acute renal failure in patients with cirrhosis.","volume":"21","author":"Moreau","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R20-26-20241201","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"R21-26-20241201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.","volume":"43","author":"Moreau","year":"2006","journal-title":"Hepatology"},{"key":"R23-26-20241201","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1478-3231.2006.01302.x","article-title":"Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.","volume":"26","author":"Schepke","year":"2006","journal-title":"Liver Int"},{"key":"R24-26-20241201","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and shortterm prognosis.","volume":"34","author":"Cardenas","year":"2001","journal-title":"Hepatology"},{"key":"R25-26-20241201","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"R26-26-20241201","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"R27-26-20241201","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00003246-198807000-00005","article-title":"Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit.","volume":"16","author":"Shellman","year":"1988","journal-title":"Crit Care Med"},{"key":"R28-26-20241201","first-page":"263","article-title":"Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit. in French.","volume":"20","author":"Castera","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"key":"R29-26-20241201","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.119.5.1489","article-title":"Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.","volume":"119","author":"Aggarwal","year":"2001","journal-title":"Chest"},{"key":"R30-26-20241201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s005350050047","article-title":"Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality.","volume":"33","author":"Singh","year":"1998","journal-title":"J Gastroenterol"},{"key":"R31-26-20241201","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"R32-26-20241201","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2006.02.013","article-title":"Upregulation of TNFalpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAKM.","volume":"45","author":"Tazi","year":"2006","journal-title":"J Hepatol"},{"key":"R33-26-20241201","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)00013-1","article-title":"Bacterial translocation of enteric organisms in patients with cirrhosis.","volume":"34","author":"Cirera","year":"2001","journal-title":"J Hepatol"},{"key":"R34-26-20241201","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/00365529709011206","article-title":"Prognostic value of plasma endotoxin levels in patients with cirrhosis.","volume":"32","author":"Chan","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R35-26-20241201","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jhep.2003.12.010","article-title":"Tumour necrosis factoralpha expression by activated monocytes and altered Tcell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin.","volume":"40","author":"Albillos","year":"2004","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"R36-26-20241201","first-page":"S64","article-title":"The epidemiology of the systemic inflammatory response.","volume":"26","author":"BrunBuisson","year":"2000","journal-title":"Intensive Care Med"},{"key":"R37-26-20241201","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.","volume":"273","author":"RangelFrausto","year":"1995","journal-title":"JAMA"},{"key":"R38-26-20241201","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1001\/jama.1992.03490240060037","article-title":"Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome).","volume":"268","author":"Bone","year":"1992","journal-title":"JAMA"},{"key":"R39-26-20241201","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1378\/chest.101.6.1481","article-title":"The ACCPSCCM consensus conference on sepsis and organ failure.","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"R40-26-20241201","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00003246-199206000-00008","article-title":"Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome.","volume":"20","author":"Moreau","year":"1992","journal-title":"Crit Care Med"},{"key":"R41-26-20241201","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","article-title":"Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"},{"key":"R42-26-20241201","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"key":"R43-26-20241201","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"R44-26-20241201","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"R45-26-20241201","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"R46-26-20241201","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/gut.2004.038679","article-title":"Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.","volume":"54","author":"Wong","year":"2005","journal-title":"Gut"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21920","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200712000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:12:16Z","timestamp":1733058736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200712000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21920","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}